Enterome vs Excalipoint Therapeutics
Enterome vs Excalipoint Therapeutics, compared side by side on 14 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Enterome is on 60/100 and Excalipoint Therapeutics on 39/100.
Where each one leads
Enterome
- our overall score: 60/100 against 39/100
- funding raised: $124M against $68.7M
Excalipoint Therapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Enterome | Excalipoint Therapeutics |
|---|---|---|
| What it is | Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases. | Developing next-generation T-cell engager therapies for cancer and autoimmune diseases. |
| Category | Biotechnology, Drug Discovery, Oncology, Immunotherapy | Biotechnology, Pharmaceuticals, HealthTech, Oncology |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | hardware | services | marketplace | platform | Platform |
| Founded | 2012 | 2025 |
| Headquarters | Paris, France | Shanghai, China |
| Status | Active | Active |
Size, funding and growth
| Measure | Enterome | Excalipoint Therapeutics |
|---|---|---|
| Employees | 33 | Not published |
| Total funding | $124M | $68.7M |
| Latest round | Later Stage VC | Seed |
| LinkedIn followers | 16,846 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Enterome | Excalipoint Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 60/100 | 39/100 |
| Traction | 55/100 | 39/100 |
| Team | 70/100 | 60/100 |
| Community | Not published | 15/100 |
| Search visibility | 34/100 | 11/100 |
| Quality | 68/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (21/100) | Not published |
| Domain ratingLink authority, 0-100 | 46/100 | Not published |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Enterome | Excalipoint Therapeutics |
|---|---|---|
| Hosting | Self Managed | Not detected |
| CMS | WordPress | Not detected |
| Frameworks | Bootstrap | Not detected |
| Analytics | Google Analytics 4, Segment | Not detected |
Enterome vs Excalipoint Therapeutics: common questions
Which is better, Enterome or Excalipoint Therapeutics?
On our 0-100 score Enterome rates higher (60/100 against 39/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 14 data points above: read the rows that match what you are buying for.
How do Enterome and Excalipoint Therapeutics compare on the numbers?
Enterome leads on our overall score (60/100 against 39/100), funding raised ($124M against $68.7M).
Read the full Enterome review and pricing or the Excalipoint Therapeutics review and pricing. You can also browse other Enterome alternatives we track.